Arca Biopharma, Inc. (ABIO)

Company Overview

ARCA biopharma, Inc. is a biotech company that focuses on the development of genetically-targeted therapies for heart failure. Their main product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator for the treatment of chronic heart failure and other indications. In the development pipeline is rNAPc2, a recombinant protein anticoagulant with a mechanism of action involving inhibition of tissue factor; and NU172, an anticoagulant, used during medical or surgical procedures. ARCA biopharma is working with a collaboration agreement with Laboratory Corporation of America to develop the test for Gencaro.

read more

Watch the video to learn about the probability of Arca Biopharma, Inc. (ABIO) Chart Signal as of Jul 29, 2016

Hotstocked Precision will calculate the probabilities of Arca Biopharma, Inc. (ABIO)

Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+


As of 10:01AM EDT July 29, 2016
$ 3.11   0.03 (0.97%)
Today's Open: 3.1 Previous Close: 3.08
Today's High: 3.14 Volume: 11,603
Today's Low: 3.1 Avg Vol: 14,432
52 Week High: 8.3998 Bid (size): 700
52 Week Low: 2.73 Ask (size): 1,300


To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 8001 Arista Place, Suite 200, Broomfield, CO 80021, United States
Mailing Address: -
Phone: 720-940-2200
Fax: 720-208-9261
Website: http//

Company Details:

Symbol: ABIO
SIC: 2835
State location: MN
Sector: -
State of Inc: MN
Employees: 22
Type: -

Key executives:

Name Age Position

Watch the video to learn about the probability of Arca Biopharma, Inc. (ABIO) Chart Signal as of Jul 29, 2016

This free program will calculate the probabilities of Arca Biopharma, Inc. (ABIO) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+


Is Arca Biopharma, inc. (NASDAQ:ABIO) Still Cheap? March 28, 2010

Who cares if Arca Biopharma, Inc. (NASDAQ:ABIO) stock tripled on Friday? Arca Biopharmaceutical is a company that over the last 2 years has invested over 60 million dollars in the development of a Heart Failure product. They appear to be making some p... read more


Bull in Advantage: ABIO Recap & More Dec 11, 2014, 09:17

  Is this email not displaying correctly? View it in your browser. Take Advantage. ARCA BioPharma, Inc. ABIO Our top performer from yesterday's report was most assuredly ABIO. We tagged this play after noticing that it had announced being granted orphan drug status by the FDA for "rNAPc2" as a potential treatment of viral hemorrhagic fever post-exposure to the Ebola read more

Promoter: Blue Horseshoe Stocks Paying Party: UNKNOWN Max Profit: 14.68% Gain at close: 0.92%
Stock: ABIO Compensation: Unknown compensation Avg $ Volume for Period: UNKNOWN

Arca Biopharma, Inc. (ABIO) MESSAGE BOARD

Post # Subject Re Name Date
There are no comments.

Type the characters that you see in the box (5 characters).